Omega-3 has been scientifically proven to improve hair and skin and even decrease the risk of heart disease.

Through advanced biotechnology, doctors are using Omega-3 to help expedite the healing process of chronic diabetic wounds and prevent infection or even amputation.

On Monday representatives from East Liverpool Hospital and EM-Media in Steubenville are heading to Iceland for a week-long research trip to learn more about this revolutionary technology.

Located in Isafjordur, Iceland a company named Kerecis has created a product called Kerecis Omega-3.

Rich in polyunsaturated fatty acids this is a product that when grafted onto a diabetic or burn wound can convert the body’s cells into living tissue. Ultimately, closing the wound at much faster rates.

The shocking part is this product is literally made of intact fish skin of codfish from the North Atlantic Ocean.

“This water is pure. It’s extremely cold so there’s not a lot of bacteria that can really flourish in this area so they have a very innovative and patented process on how they process the fish skin,” said Rick Perez, Business Director, ELCH.

On Monday, Perez will hop on a plane and head to Iceland alongside EM-Media Owner, Jim Emmerling.

“It’s the trip of a lifetime,” said Emmerling.

Together they plan to chronical their experience as they attempt to learn more not only about the Kerecis technology but the organic and pristine environment that houses these life saving scales.

“I mean we all know when you get a wound you want it clean and it’s not getting any cleaner than Iceland,” said Emmerling.

Similar treatments were used to help heal the paws of bears who were burnt in the 2018 California wildfires. Except, doctors used Talapia fish to heal those wounds, a fish that should not be used on humans according to Perez.

The Kerecis treatment is already available at the East Liverpool Health System.
The hospital has signed a two year agreement with the company giving ELCH a 48-and-a-half mile exclusivity making them the only medical facility within this region to facilitate the Kerecis procedure.

“Medicare has already approved it and certain insurance companies basically are looking at the cost benefits of it so they are in the process of accepting it because they see the value in it,” said Perez.

Following their visit, Perez and Emmerling said they hope to nationalize Kerecis Omega-3 by using their marketing footage from Iceland to promote the product.

East Liverpool Health System is a member of Prime Healthcare which owns 45 hospitals in 14 states across the U.S.